The Akkermansia Company (Public limited company)
The Akkermansia Company is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0664.529.083. It was founded on 11-10-2016. Its registered office is in Mont-Saint-Guibert. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € -3 444 264 and a loss of € 9 395 982. These accounts report 3 full-time equivalents. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 3 of its last 4 financial years.
Information last updated on 13-10-2026.
Company information
Key figures of The Akkermansia Company
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -9 395 982-158 % | € -3 645 948+27 % | € -5 024 764-19 % | € -4 234 402 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -3 444 264 | € 6 655 735-36 % | € 10 412 446+57 % | € 6 635 790 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 16 851 916-10 % | € 18 636 850+39 % | € 13 429 243+45 % | € 9 272 324 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -3 584 375-141 % | € -1 485 173+62 % | € -3 959 687-22 % | € -3 253 066 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 3-14 % | 3.5-15 % | 4.1-15 % | 4.8 |
Financial estimate
- 4 Shareholders
- 7 Board links
Similar companies
Other companies in the same activity in Mont-Saint-Guibert.
| Company | Town |
|---|---|
| Celyad Oncology | 1435 Mont-Saint-Guibert |
| Clinigen Clinical Supplies Management | 1435 Mont-Saint-Guibert |
| TICUP | 1435 Mont-Saint-Guibert |
| ERGOLABS GROUP | 1435 Mont-Saint-Guibert |
| Ncardia Holding | 1435 Mont-Saint-Guibert |
| Cellistic | 1435 Mont-Saint-Guibert |
| IMMUNOVACC CONSULTING | 1435 Mont-Saint-Guibert |
| Tools4Patient | 1435 Mont-Saint-Guibert |
Frequently asked questions
Is The Akkermansia Company still active? Yes. The Crossroads Bank for Enterprises lists The Akkermansia Company as active.
What is the VAT number of The Akkermansia Company? The VAT number of The Akkermansia Company is BE 0664.529.083.
When was The Akkermansia Company founded? The Akkermansia Company was founded on 11-10-2016.
What is the address of The Akkermansia Company? The current registered office of The Akkermansia Company is Rue Granbonpré 11, 1435 Mont-Saint-Guibert.
When did The Akkermansia Company last file annual accounts? The latest annual accounts of The Akkermansia Company were filed on 05-10-2026.
Does The Akkermansia Company file its annual accounts on time? The Akkermansia Company filed its annual accounts within the legal deadline for 3 of its last 4 financial years. Late: 2025.
How many employees does The Akkermansia Company have? The Akkermansia Company employs 3 full-time equivalents according to its most recent annual accounts.
Is The Akkermansia Company financially healthy? Addrly gives The Akkermansia Company a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is The Akkermansia Company profitable? The annual accounts of The Akkermansia Company for 2025 show a loss of € 9 395 982.
What is the equity of The Akkermansia Company? The equity of The Akkermansia Company was € -3 444 264 at the close of the 2025 financial year.
Who are the directors of The Akkermansia Company? The annual accounts of The Akkermansia Company record 15 mandates. The names, roles and dates are visible with a free account.
Can The Akkermansia Company receive Peppol e-invoices? Yes. The Akkermansia Company is registered on the Peppol network and can receive structured electronic invoices.
What does The Akkermansia Company do? The main activity of The Akkermansia Company is: Scientific research and development.